Evidence map›Paper›PMID 26618001›Full record

ReviewPulmonary medicine2015

Statins in Asthma: Potential Beneficial Effects and Limitations.

Dipanjan Bhattacharjee, Bharti Chogtu, Rahul Magazine

Open access · goldAbstract readReview
In one paragraph

Review in Pulmonary medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Sterols and immune mechanisms in asthma.The Journal of allergy and clinical immunology · 2023
    Review
  2. Article
  3. Sterols in asthma.Trends in immunology · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Innovations in asthma therapy: is there a role for inhaled statins?Expert review of respiratory medicine · 2018
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dipanjan BhattacharjeeDepartment of Pharmacology, Kasturba Medical College, Manipal University, Manipal 576104, India.
Bharti ChogtuDepartment of Pharmacology, Kasturba Medical College, Manipal University, Manipal 576104, India.
Rahul MagazineDepartment of Pulmonary Medicine, Kasturba Medical College, Manipal University, Manipal 576104, India.
Manipal Academy of Higher Education · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma's sustenance as a global pandemic, across centuries, can be attributed to the lack of an understanding of its workings and the inability of the existing treatment modalities to provide a long lasting cure without major adverse effects. The discovery of statins boosted by a better comprehension of the pathophysiology of asthma in the past few decades has opened up a potentially alternative line of treatment that promises to be a big boon for the asthmatics globally. However, the initial excellent results from the preclinical and animal studies have not borne the results in clinical trials that the scientific world was hoping for. In light of this, this review analyzes the ways by which statins could benefit in asthma via their pleiotropic anti-inflammatory properties and explain some of the queries raised in the previous studies and provide recommendations for future studies in this field.

Indexed as

AnimalsAsthmaClinical Trials as TopicHumansHydroxymethylglutaryl-CoA Reductase InhibitorsRespiratory SystemHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID26618001
PMCPMC4651730
OpenAlexW2187778560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.